← FDA DRUG APPROVALS

FDA ANDA · ANDA080658

PROCAINE HYDROCHLORIDE

Sponsor: WATSON LABS

APPLICATION
ANDA080658
TYPE
ANDA
ORIGINAL APPROVAL
1974-04-01
LATEST ACTION
1999-02-19
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

PROCAINE HYDROCHLORIDEDiscontinued
PROCAINE HYDROCHLORIDE 2% · INJECTABLE · INJECTION
PROCAINE HYDROCHLORIDEDiscontinued
PROCAINE HYDROCHLORIDE 1% · INJECTABLE · INJECTION

Approval history

1999-02-19Manufacturing (CMC) · Supplement 21AP
1999-02-02Manufacturing (CMC) · Supplement 20AP
1997-04-10Manufacturing (CMC) · Supplement 18AP
1996-08-26Manufacturing (CMC) · Supplement 19AP
1994-09-27Labeling · Supplement 14AP
1994-09-27Labeling · Supplement 15AP
1992-01-27Manufacturing (CMC) · Supplement 16AP
1992-01-27Manufacturing (CMC) · Supplement 17AP
1988-12-23Manufacturing (CMC) · Supplement 12AP
1988-12-23Manufacturing (CMC) · Supplement 11AP
1986-07-25Manufacturing (CMC) · Supplement 7AP
1974-04-01OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →